Patents by Inventor Vijay Koya
Vijay Koya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11883655Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system herein can include an electric field generating circuit configured to generate one or more electric fields, and control circuitry. The system can include one or more electrodes disposed on a first stimulation lead to deliver the electric fields to a site of a cancerous tumor within a patient and one or more electrodes disposed on a second stimulation lead to deliver the electric fields to the site of a cancerous tumor within a patient. The first and second stimulation leads can be configured to be implanted on or about a duodenum. The electric field generating circuit can generate electric fields at frequencies selected from a range of between 10 kHz to 1 MHz. Other embodiments are also included herein.Type: GrantFiled: February 23, 2021Date of Patent: January 30, 2024Assignee: Boston Scientific Scimed, Inc.Inventors: Kyle Harish Srivastava, Vijay Koya, Thomas Lee Williams, Miles Kealy, Nicholas Barron
-
Publication number: 20220218241Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.Type: ApplicationFiled: March 29, 2022Publication date: July 14, 2022Inventors: Vijay Koya, Bryan Allen Clark, Kyle Harish Srivastava, Michael X. Govea, Elizabeth Mary Annoni
-
Patent number: 11304633Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.Type: GrantFiled: November 2, 2018Date of Patent: April 19, 2022Assignee: Boston Scientific Scimed, Inc.Inventors: Vijay Koya, Bryan Allen Clark, Kyle Harish Srivastava, Michael X. Govea, Elizabeth Mary Annoni
-
Publication number: 20220080154Abstract: A navigation-assisting flexible elongate member, a navigation-assisting system, and a navigation-assisting method for use in navigating within a body to a treatment site. A navigation-assisting sensor, such as an optic fiber, an inductive sensor, a piezoelectric sensor, or a camera, is provided within the wall of the flexible elongate member, so as not to occupy space within a working channel defined by and through the flexible elongate member. When the distal end of the flexible elongate encounters an obstacle/another object (e.g., body tissue or a lumen wall), the navigation-assisting sensor generates a signal indicative of such encounter. Such signal is converted into information (such as by a control unit) usable to navigate the flexible elongate member away from the obstacle and on course to the treatment site.Type: ApplicationFiled: September 13, 2021Publication date: March 17, 2022Inventors: Kyle H. Srivastava, Vijay Koya, Jonathan B. Shute, Christopher Piere, Mark Kringle
-
Publication number: 20210341409Abstract: Embodiments herein relate to non-invasive bladder cancer detection systems and methods. In an embodiment, a method for detecting a disease state in a subject is included. The method includes obtaining a liquid biological sample from the subject and placing it into a container and contacting the liquid biological sample with a first chemical sensor element, where the first chemical sensor element can include a plurality of discrete graphene varactors. The method can include sensing and storing capacitance of each of the discrete graphene varactors to obtain a first sample data set. Other embodiments are also included herein.Type: ApplicationFiled: April 28, 2021Publication date: November 4, 2021Inventors: Christopher Brian Rognrud, Vijay Koya, August Judisch, Anthony Frank Tassoni, JR., Gregory J. Sherwood, Kate Louise Frost, Justin Theodore Nelson
-
Publication number: 20210260370Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system herein can include an electric field generating circuit configured to generate one or more electric fields, and control circuitry. The system can include one or more electrodes disposed on a first stimulation lead to deliver the electric fields to a site of a cancerous tumor within a patient and one or more electrodes disposed on a second stimulation lead to deliver the electric fields to the site of a cancerous tumor within a patient. The first and second stimulation leads can be configured to be implanted on or about a duodenum. The electric field generating circuit can generate electric fields at frequencies selected from a range of between 10 kHz to 1 MHz. Other embodiments are also included herein.Type: ApplicationFiled: February 23, 2021Publication date: August 26, 2021Inventors: Kyle Harish Srivastava, Vijay Koya, Thomas Lee Williams, Miles Kealy, Nicholas Barron
-
Publication number: 20200215266Abstract: A system may include an input device configured to receive a signal indicative of elevated glucose in a patient, and an electrical stimulator configured to electrically stimulate at least one skeletal muscle. The system may further include a controller operably connected to the electrical stimulator. The controller may be configured for delivering a glucose therapy in response to the signal by controlling the electrical stimulator. The system may be configured to deliver the therapy in combination with other glucose therapies, and the therapy may be titrated based on a sensed parameter or patient feedback.Type: ApplicationFiled: January 2, 2020Publication date: July 9, 2020Inventors: Vijay Koya, Bryan Allen Clark, Keith R. Maile, Michael J. Kane, Jeffrey E. Stahmann, Elizabeth Mary Annoni
-
Publication number: 20200069366Abstract: A system and method for denervation where a catheter includes a radially expandable member, the radially expandable member including an exterior surface, a plurality of electrodes on the exterior surface configured for delivery of energy during a denervation procedure in a vessel, and a chemical agent coating on the exterior surface, wherein the chemical agent inhibits or prevents nerve regeneration. The radially expandable member is configured to have a first unexpanded configuration and a second expanded configuration, and is configured to bring the exterior surface in contact with a wall of a vessel when it is in the expanded configuration.Type: ApplicationFiled: August 28, 2019Publication date: March 5, 2020Inventors: Bryan Allen Clark, Vijay Koya, Elizabeth M. Annoni, Hong Cao
-
Publication number: 20190254740Abstract: Devices, systems, and methods for regulating glucose levels, including treating diabetes, in accordance with the present disclosure may include a catheter having an expandable or inflatable portion, one or more electrodes disposed on the expandable or inflatable portion of the catheter, wherein the electrodes are configured to deliver energy to a patient's gastrointestinal tract, and a drug delivery mechanism for delivering a drug therapy subsequent to energy delivery by the electrodes. A method for regulating glucose levels according to the present disclosure may include inserting a catheter into a patient's gastrointestinal tract, positioning the catheter in a duodenum of the patient's gastrointestinal tract, expanding or inflating a portion of the catheter in the duodenum, the expandable or inflatable portion of the catheter including electrodes, applying energy to the duodenum via the electrodes to ablate tissue of the duodenum, and delivering a drug therapy to the ablated tissue of the duodenum.Type: ApplicationFiled: February 19, 2019Publication date: August 22, 2019Inventors: Vijay Koya, Elizabeth M. Annoni, Bryan A. Clark, Bruce Forsyth, Hong Cao, Matthew R. DeWitt, Kyle H. Srivastava
-
Publication number: 20190125227Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.Type: ApplicationFiled: November 2, 2018Publication date: May 2, 2019Inventors: Vijay Koya, Bryan Allen Clark, Kyle Harish Srivastava, Michael X. Govea, Elizabeth Mary Annoni
-
Publication number: 20190125226Abstract: A system may include a controller operably connected to a diabetic therapy delivery system. The controller may be configured to: receive therapy inputs including a therapy input indicative of a glucose measure; determine a therapy input index using the at least one therapy input including the therapy input indicative of a glucose measure; map the determined therapy input index to a graded glucose control; and set the graded glucose control based on the mapped graded glucose control for the determined therapy input index, wherein the graded glucose control includes at least one of a neuromodulation target, a neuromodulation type, or at least one neuromodulation parameter value. The diabetic therapy delivery system may be configured to deliver the therapy for graded glucose control using the graded glucose control that was set based on the mapped graded glucose control.Type: ApplicationFiled: November 2, 2018Publication date: May 2, 2019Inventors: Vijay Koya, Bryan Allen Clark, Kyle Harish Srivastava, Michael X. Govea, Elizabeth Mary Annoni
-
Publication number: 20120039919Abstract: As described below, the present invention features compositions and methods featuring Pdx-1 polypeptides and fragments thereof for the diagnosis, prevention and treatment of diabetes.Type: ApplicationFiled: August 5, 2011Publication date: February 16, 2012Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.Inventors: Lijun Yang, Vijay Koya, Shi-Wu Li